Chapter 283 (1/2)
At the time of the global biology thriving, the long Kang pharmaceutical of the Xu family in Lucheng, Jiangzhou is also developing rapidly.
Although the medicine of Zhuang Yang is a thing that can not take the table, its ability to make money is to make any pharmaceutical company greedy, and the God of love is just a crazy ”God medicine” for men.
Sales are climbing the peak.
The sales volume of single day in 2019 reached 2million, which makes the industry envy and hate.
It was thought that this was already a number, but by 2020, sales were not only weak, but also constantly refreshing new records.
New year's Eve sales will be 3 million by 2020!
February 14 Valentine's Day sells 4million!
38 women's festival sales of 5 million!
The night before Labor Day May 1, sales reached an amazing 7 million.
Such sales, so that the senior level of Longkang pharmaceutical are all smiling.
It turns out that men don't like to use Zhuang Yang drugs, but many drugs are under the banner of Zhuang Yang, and they have been reluctant to buy them over time.
And the God of love does not advertise, relying solely on the mass power of oral communication, and then in less than a year, climbed to the first trading chair of domestic Zhuang Yang medicine.
If calculated by 7 million daily sales, the annual sales will reach a terrible 2.55 billion RMB, or US $365million.
According to Pfizer's 2019 report, the global sales of vieco in 2019 are only $1.5 billion, while aeolian has reached 24 percent of its market in China alone.
Once it is sold globally, more than one thousand Aiko will be available in the near future.
At this time, in the office of chairman of Kyoto Longkang pharmaceutical, Xu Yuting looked at yesterday's sales statistics of Aili God, and he was also unable to help showing his joy.
A company product is the first in the industry, representing not only money, but also a recognition degree of the market, and an honor.
Of course, market recognition represents money
Xu Yuting looked beyond the spirit of love, and looked at the sales report of other products of the company, and soon the smile at the corner of her mouth was gone.
Although the market environment is not good in 2020, the financial crisis caused by the United States swept the world, leading to the economic downturn in all countries, but the medical industry is rising against the trend, the performance of major pharmaceutical companies has doubled, and the share price has been innovating high.
Longkang pharmaceutical is no exception, and its sales of products have greatly improved compared with last year.
However, the short board of Longkang pharmaceutical is also obvious, and the innovation is insufficient. All the first and second class new drugs sold are all imitative drugs acting from abroad, while the drugs independently developed are mostly 45.6 kinds of drugs, even three are few.
Although it is clear that scientific research is not done overnight, it is still frustrating.
Compared with a series of foreign agents, at this time, the high hanging in the top 1 of the sales table of the spirit of love, appears to stand out.
Xu put down the sales report and asked, ”what has been the latest move of Huanyu biology?”
”I'm going to tell you they are developing a new drug for hepatitis B and it's said that screening of active compounds has been completed,” said the executive director
Xu Yuting was surprised and said, ”what, is it really fake?”
The executive director nodded and said, ”it should be accurate! Hejunfeng, deputy director of hepatitis B Institute of Chinese Academy of Sciences, has been hired to join Huanyu biology. The specific job website has not been published. ”
”Hepatitis B......”
Xu Yuting's left index finger is constantly knocking on the table, frowning and chanting.
Huanyu biology is really a fierce one. In general, a new drug clinical trial of one kind in a year is amazing, but they have already entered the clinical trial stage of two new drugs of class I.
The special drug of HIV, which has been paid attention to, has passed the first phase of clinical trial and entered the second phase of clinical trial. The pharmaceutical community is very happy.
Second, a new anti sensitive drug which has just entered clinical trials, which is said to be effective in the treatment of cough caused by allergies, and has a very good effect on pollen.